1. DSpace at My University
  2. E-Journal
  3. Teknologi Bank Darah
  4. Jurnal Nasional
  5. Acta Medica Indonesiana
  6. VOL 54 NO 3 2022
Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/8897
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSukmadi, Norman-
dc.contributor.authorSurya, Kevin-
dc.contributor.authorSejati, Arif-
dc.date.accessioned2024-12-13T02:53:54Z-
dc.date.available2024-12-13T02:53:54Z-
dc.date.issued2022-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/8897-
dc.description.abstractThis is a literature review of the use of aquaretic in patients with acute decompensated heart failure (ADHF), including the physiologic function of vasopressin and its mechanism of action in heart failure patients, and aquaretic drugs with their respective risks and benefits. Vasopressin is one of several hormones that can cause hyponatremia and worsen congestion in ADHF patients. Aquaretics are a class of drugs that have an antagonistic effect on vasopressin receptors, especially V2R. Aquaretics use in ADHF patients can provide relief for congestive symptoms with no serious adverse effects. In-depth additional understanding regarding aquaretics may be useful for clinical judgments in treating ADHF patients. Keywords: acute decompensated heart failure (ADHF), aquareticsen_US
dc.subjectacute decompensated heart failure (ADHF), aquaretics.en_US
dc.titleAquaretics Use in Acute Decompensated Heart Failure (ADHF) Patients: A Literature Reviewen_US
dc.typeArticleen_US
Appears in Collections:VOL 54 NO 3 2022

Files in This Item:
File Description SizeFormat 
17.pdf389.06 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.